PCIG
NBP

Partners Capital Investment Group’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Partners Capital Investment Group’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-221,326
Closed -$2.5M – 138
2022
Q2 		$2.5M Buy
221,326
+24,977
+13% +$299K 0.17% 80
2022
Q1 		$3.19M Buy
196,349
+85,380
+77% +$2.19M 0.16% 83
2021
Q4 		$5.26M Buy
+110,969
New +$6.66M 0.24% 76

Other funds holding NBP

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Cederberg Capital London, United Kingdom $186M AUM 21.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Partners Capital Investment Group's NBP Position: Q3 2022 in Review

Partners Capital Investment Group sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q3 2022, closing a stake of 221,326 shares — an estimated $2.5M sold.

Partners Capital Investment Group first reported a position in NBP in Q4 2021 and held it in 3 quarters. The position peaked at $5.26M in Q4 2021. 75 funds tracked by Wall St. Rank hold NBP as of Q3 2022.

  • Partners Capital Investment Group reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q3 2022 after selling out during the quarter.
  • Partners Capital Investment Group sold 221,326 NovaBridge Biosciences American Depositary Shares shares in Q3 2022, an estimated $2.5M.
  • Partners Capital Investment Group first reported a position in NovaBridge Biosciences American Depositary Shares in Q4 2021 and held it in 3 quarters.
  • Partners Capital Investment Group's NovaBridge Biosciences American Depositary Shares position peaked at $5.26M in Q4 2021.
  • 75 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q3 2022.

Based on Partners Capital Investment Group's 13F filing for Q3 2022, filed 14 Nov 2022.